FDA recall D-0301-2022
SterRx, LLC · Class II · drug
Product
Morphine Sulfate in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY, 12903, NDC 70324-427-02.
Reason for recall
Lack of Assurance of Sterility
Distribution
U.S.A. Nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2021-11-12
- Report date
- 2022-01-05
- Termination date
- 2023-12-06
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Plattsburgh, NY, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0301-2022